These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34156077)

  • 1. HepCCATT: a multilevel intervention for hepatitis C among vulnerable populations in Chicago.
    Tilmon S; Aronsohn A; Boodram B; Canary L; Goel S; Hamlish T; Kemble S; Lauderdale DS; Layden J; Lee K; Millman AJ; Nelson N; Ritger K; Rodriguez I; Shurupova N; Wolf J; Johnson D
    J Public Health (Oxf); 2022 Dec; 44(4):891-899. PubMed ID: 34156077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enablers and barriers for the provision of community-based HCV treatment: A case study of a real-world practice.
    Pourmarzi D; Smirnov A; Hall L; Thompson H; FitzGerald G; Rahman T
    J Viral Hepat; 2020 May; 27(5):484-496. PubMed ID: 31958355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Management and Capacity Building to Enhance Hepatitis C Treatment Uptake at Community Health Centers in a Large Urban Setting.
    Boodram B; Kaufmann M; Aronsohn A; Hamlish T; Peregrine Antalis E; Kim K; Wolf J; Rodriguez I; Millman AJ; Johnson D
    Fam Community Health; 2020; 43(2):150-160. PubMed ID: 32079971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine Screening and Linkage to Care for Hepatitis C Virus in an Urban Safety-Net Health System, 2017-2019.
    Hunt BR; Ahmed C; Ramirez-Mercado K; Patron C; Glick NR
    Public Health Rep; 2021; 136(2):219-227. PubMed ID: 33176114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Among High-Risk Alabamians: Disease Burden and Screening Effectiveness.
    Lee AB; Karumberia S; Gilmore A; Williams E; Bruner N; Overton ET; Saag MS; Franco RA
    J Infect Dis; 2020 Sep; 222(Suppl 5):S365-S375. PubMed ID: 32877566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sharing the cure: Building primary care and public health infrastructure to improve the hepatitis C care continuum in Maryland.
    Irvin R; Ntiri-Reid B; Kleinman M; Agee T; Hitt J; Anaedozie O; Arowolo T; Cassidy-Stewart H; Bush C; Wilson LE; Millman AJ; Nelson NP; Canary L; Brinkley S; Moon J; Falade-Nwulia O; Sulkowski MS; Thomas DL; Melia MT
    J Viral Hepat; 2020 Dec; 27(12):1388-1395. PubMed ID: 32671942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.
    Lebovics E; Torres R; Porter LK
    Am J Med; 2017 Feb; 130(2):S1-S2. PubMed ID: 28087291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can hepatitis C be eradicated in the United States?
    Edlin BR; Winkelstein ER
    Antiviral Res; 2014 Oct; 110():79-93. PubMed ID: 25110202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations.
    Ford MM; Jordan AE; Johnson N; Rude E; Laraque F; Varma JK; Hagan H
    J Public Health Manag Pract; 2018; 24(1):41-48. PubMed ID: 28141668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening, diagnosis, treatment, and management of hepatitis C: a novel, comprehensive, online resource center for primary care providers and specialists.
    Lebovics E; Czobor K
    Am J Med; 2014 Nov; 127(11):e11-e14. PubMed ID: 25308624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot.
    Stämpfli D; Imfeld-Isenegger TL; Hersberger KE; Messerli M
    BMC Infect Dis; 2023 Jun; 23(1):384. PubMed ID: 37286975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations.
    Turner BJ; Rochat A; Lill S; Bobadilla R; Hernandez L; Choi A; Guerrero JA
    Ann Intern Med; 2019 Dec; 171(12):865-874. PubMed ID: 31791065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underdiagnosis of hepatitis C in the community: do not forget vulnerable populations.
    Ng A
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1095. PubMed ID: 35048677
    [No Abstract]   [Full Text] [Related]  

  • 15. HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility study.
    Barror S; Avramovic G; Oprea C; Surey J; Story A; Macías J; Cullen W; Crowley D; Horan A; Naughton AM; Iglesias M; Ianache I; Lazar S; Popa I; McHugh T; Menezes D; Tinago W; Lambert JS
    J Antimicrob Chemother; 2019 Nov; 74(Suppl 5):v39-v46. PubMed ID: 31782499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver health events: an indigenous community-led model to enhance HCV screening and linkage to care.
    Pandey M; Konrad S; Reed N; Ahenakew V; Isbister P; Isbister T; Gallagher L; Campbell T; Skinner S
    Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34125199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital.
    Tran AN; Sachdev R; Fricker ZP; Leber M; Zahorian T; Shah B; Nunes DP; Long MT
    Dig Dis Sci; 2018 Dec; 63(12):3241-3249. PubMed ID: 30078116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison.
    Ward Z; Mafirakureva N; Stone J; Keevans M; Betts-Symonds G; Crowley D; McHugh T; Avramovic G; Lambert JS; Vickerman P
    Int J Drug Policy; 2021 Oct; 96():103394. PubMed ID: 34412938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of a Pharmacist-Led Hepatitis C Virus Treatment Program in an Urban Safety-Net Health System, Chicago, 2017-2019.
    Hunt BR; Cetrone H; Sam S; Glick NR
    Public Health Rep; 2022; 137(4):702-710. PubMed ID: 34043923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Hepatitis C Virus: How Universal Is Universal?
    Jhaveri R
    Clin Ther; 2020 Aug; 42(8):1434-1441. PubMed ID: 32712026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.